Sensex
77,264.51 profit arw 330.92 (0.43%)
Nifty
24,175.65 profit arw 84.80 (0.35%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 26-Aug-2026
Corporate News
26-Aug-2026     20:39

Senores Pharmaceuticals appoints Dr. Shah, plans subsidiaries in Mexico and Canada

Senores Pharmaceuticals Limited announced several corporate actions, including the appointment of Dr. Viranchi Arvindbhai Shah as an independent director, bringing extensive experience in pharmaceuticals, government policy, and education to the board. The company also approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026, granting 4,72,000 options, representing 1% of the company's equity, to eligible employees with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals is planning to incorporate a wholly-owned subsidiary in Mexico and a subsidiary company in Canada, with investments of 100% and 51% or more respectively, to expand its presence in those markets, pending regulatory approvals.

INDIAN INDICES

Sensex

77,264.51 330.92 (0.43%)

Nifty

24,175.65 84.80 (0.35%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,584.80 19.05(0.07%)